Filing Flows › Orthofix Medical (OFIX) › Q3 FY26 › vs Q3 FY25
Orthofix Medical (OFIX) Q3 FY26 vs Q3 FY25 (year over year)
Orthofix Medical's revenue rose $2.2M (+1%) from $206M in Q3 FY25 to $208M in Q3 FY26. The biggest changes: Global Limb Reconstruction +$2.8M (+8%); Global Spine −$614K (-0.4%).
Orthofix Medical, Q3 FY26: revenue $208M (+1% year over year), operating margin 0.7%, net loss $6.1M, operating cash flow $363K. The chart draws each line against Q3 FY25, the increases inside each band.
Every line
| Line | Q3 FY26 | Q3 FY25 | Change | % |
|---|---|---|---|---|
| Global Spine | $171M | $172M | −$614K | -0.4% |
| Global Limb Reconstruction | $36.4M | $33.6M | $2.8M | +8% |
| Revenue | $208M | $206M | $2.2M | +1% |
| Net loss | $6.1M | $22.8M | −$16.7M | -73% |
| Costs & expenses | $214M | $228M | −$14.5M | -6% |
| Operating costs | $206M | $223M | −$16.4M | -7% |
| Interest & other, net | $6.8M | $5.2M | $1.6M | +30% |
| Income tax | $826K | $533K | $293K | +55% |
| Cost of revenue | $61.3M | $57.1M | $4.2M | +7% |
| Research & development | $15.3M | $14.8M | $503K | +3% |
| SG&A | $125M | $148M | −$22.8M | -15% |
| Other operating costs | $4.4M | $2.7M | $1.7M | +63% |
| Operating cash sources | $19.9M | $20.1M | −$206K | -1% |
| Depreciation & amortization | $13.2M | $12.9M | $231K | +2% |
| Share-based compensation | $6.7M | $7.2M | −$437K | -6% |
| Net loss absorbed | $6.1M | $22.8M | −$16.7M | -73% |
| Working capital & other | $13.5M | −$15.1M | $28.6M | — |
| Operating cash flow | $363K | $12.4M | −$12.0M | -97% |
| Capital expenditures | $14.5M | $9.9M | $4.6M | +46% |
| Negative free cash flow (OCF − capex) | $14.1M | −$2.5M | $16.6M | — |
Questions
How much did Orthofix Medical's revenue grow year over year in Q3 FY26?
Orthofix Medical's revenue rose $2.2M (+1%) from $206M in Q3 FY25 to $208M in Q3 FY26.
What drove Orthofix Medical's revenue change in Q3 FY26?
Global Limb Reconstruction +$2.8M (+8%); Global Spine −$614K (-0.4%).